Retrospective Analysis of U.S. Claims Data Shows AUVI-Q® (epinephrine injection, USP) Prescription Associated with Lower Rates of Anaphylaxis-Related Inpatient Hospitalizations Compared to Other ...

AUVI-Q (epinephrine injection, USP) Auto-injector is a prescription medicine used to treat emergency allergic reactions, including anaphylaxis, in people who are at risk for or who have a history of ...

AUVI-Q (R) (epinephrine injection, USP) is still available by prescription for children with life-threatening allergies. Most kids spend the final weeks of summer amassing school supplies and cramming ...

Richmond, Virginia, July 24, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced that AUVI-Q® (epinephrine injection, USP) ...

Richmond, Virginia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Kaléo, a privately-held U.S. pharmaceutical company has announced a redesign of the AUVI-Q® (epinephrine injection, USP) commercial team structure ...

BRIDGEWATER, N.J., Oct. 28, 2015 /PRNewswire/ -- Sanofi US is voluntarily recalling all Auvi-Q ® (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both ...

Richmond, Virginia, May 15, 2025 (GLOBE NEWSWIRE) -- New findings from a retrospective analysis of U.S. commercial claims data indicate that patients prescribed AUVI-Q ® (epinephrine injection, USP) ...

The MarketWatch News Department was not involved in the creation of this content. Retrospective Analysis of U.S. Claims Data Shows AUVI-Q(R) (epinephrine injection, USP) Prescription Associated with ...